Three semiconductor names are generating the loudest options noise right now. The catalyst backdrop is packed.
INTC has surged 15% in recent sessions. Short interest collapsed 55% in just one week to roughly 103,000 shares. That violent short squeeze is forcing repositioning in the options market. Near-dated expiries on June 22 and June 26 show active positioning — traders are scrambling ahead of further moves.
MU reports earnings this week. The stock has one of the most densely populated option chains in the market right now, with 23 expiry dates stretching from June 24 through September 2026. That breadth signals heavy hedging and speculative activity around the print.
AMAT is also in focus after its CEO filed a large insider sale. Multiple near-term expiries — June 22 and June 23 — are live, pointing to short-dated put buying as a hedge.
Meanwhile, MRNA is the wildcard. Its FDA advisory committee backed the flu vaccine 9-0 this week. Short interest sits at 15.5% of free float — elevated relative to the three semi names. Call-side open interest clustered around the $35 strike expiring June 26 shows traders positioning for a continued bounce on the approval tailwind.
Fund managers are also broadly piling into global semiconductors. 80% of surveyed funds now hold the trade, per market data — a crowded positioning that raises tail risk. SPY and QQQ options desks will be watching the semis closely for any rotation catalyst.
This note is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
